Park Ha Biological Technology Co., Ltd. Capital Reinvestment Ratio

Latest as of October 2024: 0.09x

Park Ha Biological Technology Co., Ltd. capital reinvestment ratio. Park Ha Biological Technology Co., Ltd. (BYAH) has a Capital Reinvestment Ratio of 0.09x as of October 2024, meaning it reinvests 0% of its operating cash flow ($960.47K) in capital expenditures ($85.57K). Check BYAH total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.09x
Capex / Operating Cash Flow

Operating Cash Flow

$960.47K
USD

Capital Expenditures

$85.57K
USD

Data as of

Oct 2024
Most recent filing

Capital Reinvestment Ratio of Park Ha Biological Technology Co., Ltd. (2022–2024)

Capital reinvestment ratio of Park Ha Biological Technology Co., Ltd. from 2022 to 2024. This chart tracks Park Ha Biological Technology Co., Ltd.'s Capital Reinvestment Ratio across 3 annual periods. Also explore Park Ha Biological Technology Co., Ltd. equity growth rate to track the company's year-over-year net asset growth rate.

Park Ha Biological Technology Co., Ltd. Capital Reinvestment Ratio by Year (2022–2024)

Park Ha Biological Technology Co., Ltd. capital reinvestment ratio by year from 2022 to 2024. For the full cash flow conversion analysis, see BYAH cash generation efficiency.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2024 0.09x $960.47K $85.57K ▼ -50.3%
2023 0.18x $126.54K $22.68K ▲ +2073.8%
2022 0.01x $1.44 Million $11.89K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow